Senior insider sale
Chief Financial Officer at NURIX THERAPEUTICS, INC. — senior position signals high conviction
$121.4K
9.41K shares
What this filing means
VAN HOUTE HANS plans to sell 9.41K shares of NURIX THERAPEUTICS, INC. valued at approximately $121.4K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 11/3/2025ACC: 0001950047-25-008397
Officer· Chief Financial Officer
Since Jul 2020
9.41K
Shares to sell
$121.4K
Approx. market value
6.28K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Units
N/A
10/30/2025
6.28KTotal acquired6.28K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
10/30/2025 | Restricted Stock Units N/A | 6.28K | — |
| Total | 6.28K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
3.13K
Market value
$40.1K
10/30/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
6.28K
Market value
$81.3K
11/3/2025
Total
Units
9.41K
Value
$121.4K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
10/30/2025 | 3.13K | $40.1K | — | Completed |
| Planned — Approximate Date | ||||
11/3/2025 | 6.28K | $81.3K | NASDAQ | Planned |
| Total | 9.41K | $121.4K | ||